Ventyx Biosciences, Inc.

Contributing Author

Recent Articles by Ventyx Biosciences, Inc.

Jun-17	Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson's Disease VTYX GlobeNewswire
May-28	Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference VTYX GlobeNewswire
May-08	Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress VTYX GlobeNewswire